# Reversal of Residual Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine

> **NCT03656614** · — · COMPLETED · sponsor: **Guangzhou General Hospital of Guangzhou Military Command** · enrollment: 121 (actual)

## Conditions studied

- Neuromuscular Blockade

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine
- **DRUG:** Saline 0.9%

## Key facts

- **NCT ID:** NCT03656614
- **Lead sponsor:** Guangzhou General Hospital of Guangzhou Military Command
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-26
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-30
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03656614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03656614, "Reversal of Residual Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03656614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*